Literature DB >> 15634819

Impaction grafting in revision total elbow arthroplasty.

Mark I Loebenberg1, Robert Adams, Shawn W O'Driscoll, Bernard F Morrey.   

Abstract

BACKGROUND: Revision total elbow arthroplasty is often undertaken in patients who have severe osteolysis of both the distal part of the humerus and the proximal part of the ulna. To deal with such bone loss, we have adopted the practice of impaction grafting, which has become a well-established technique in the proximal part of the femur.
METHODS: We retrospectively reviewed the results of twelve patients who had undergone revision total elbow arthroplasty with impaction grafting between 1993 and 1997. There were eight women and four men with a mean age of fifty-seven years. All patients were followed for at least two years (range, twenty-five to 113 months), with an average duration of follow-up of seventy-two months. Seven of the patients had an initial diagnosis of rheumatoid arthritis, and five had posttraumatic arthritis. Impaction grafting was undertaken during the initial revision in three of the patients, whereas the remaining nine patients had undergone at least one prior revision without impaction grafting. Four patients had impaction grafting on the ulnar side alone, six had it on the humeral side alone, and two underwent impaction grafting of both the humerus and the ulna. Six allograft struts were placed to span structural defects in five patients.
RESULTS: At the time of the latest follow-up, eight of the elbow prostheses were intact after the index impaction grafting procedure. Two elbows had been revised because of loosening, and another had been revised because of a fracture of the ulnar component. A fourth patient had undergone a resection arthroplasty because of infection. The eight remaining patients demonstrated marked radiographic improvement in bone quality in the region of the impaction graft without clinical symptoms of loosening. At the time of the last follow-up, after an additional revision in three elbows, there were five excellent, four good, and three fair results.
CONCLUSIONS: Impaction grafting is a reliable technique for treating osteolysis in patients undergoing revision total elbow arthroplasty; however, complications can occur, and a high percentage of patients need additional surgery.

Entities:  

Mesh:

Year:  2005        PMID: 15634819     DOI: 10.2106/JBJS.B.00038

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  8 in total

Review 1.  [Allograft reconstruction in revision elbow arthroplasty].

Authors:  F Moro
Journal:  Orthopade       Date:  2017-12       Impact factor: 1.087

Review 2.  [Revision arthroplasty of the elbow].

Authors:  K J Burkhart; G Stein; E Skouras; L P Müller
Journal:  Unfallchirurg       Date:  2010-12       Impact factor: 1.000

Review 3.  There is a role for allografts in reconstructive surgery of the elbow and forearm.

Authors:  R J Molenaars; B J A Schoolmeesters; J Viveen; B The; D Eygendaal
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2018-10-19       Impact factor: 4.342

4.  Impaction Grafting in Revision Total Elbow Arthroplasty for Aseptic Loosening and Bone Loss: Surgical Technique.

Authors:  Yong Girl Rhee; Nam Su Cho; Chong Suck Parke
Journal:  JBJS Essent Surg Tech       Date:  2013-09-11

5.  Total elbow arthroplasty.

Authors:  Joaquin Sanchez-Sotelo
Journal:  Open Orthop J       Date:  2011-03-16

6.  Use of a femoral impaction grafting system in revision total elbow arthroplasty.

Authors:  J D Kosy; R P Walter; V B L Conboy; S M Blake
Journal:  Ann R Coll Surg Engl       Date:  2011-07       Impact factor: 1.951

7.  Pseudotumor due to metallosis after total elbow arthroplasty.

Authors:  Roberto Rotini; Graziano Bettelli; Michele Cavaciocchi; Lucia Savarino
Journal:  Indian J Orthop       Date:  2017 Jan-Feb       Impact factor: 1.251

8.  Minor influence of humeral component size on torsional stiffness of the Souter-Strathclyde total elbow prosthesis.

Authors:  Joris C T van der Lugt; Daniel R Suarez; Tim J van der Steenhoven; Rob G H H Nelissen
Journal:  Int Orthop       Date:  2009-12-01       Impact factor: 3.075

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.